Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 214 matches for

RDM researchers collaborate on postpartum blood pressure self-monitoring trial in the US

Researchers in RDM’s Cardiovascular Clinical Research Facility (CCRF) will collaborate with the University of Pennsylvania on a new trial to understand the potential benefits of postpartum blood pressure monitoring in the US healthcare system.

Researchers provide a perspective on mapping the bone marrow using new spatial transcriptomic technologies

RDM researchers have outlined the potential benefits and limitations of new spatial transcriptomic technologies for mapping the bone marrow in patients with blood cancer.

Support for RDM research in diagnosing and managing heart failure

The Kusuma Trust has made an award of £400K to fund research in diagnosing and managing heart failure.

Study to evaluate treatment of Autonomous Cortisol Secretion

New MRC Centre to create cutting-edge gene therapies

Professor Deborah Gill is to co-lead an MRC research centre being launched to develop new advanced treatments for currently untreatable diseases.

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.

Davis Group receives Wellcome Discovery Award

Professor Simon Davis and Dr Mafalda Santos have won a 5-year award from the global charitable foundation Wellcome to fund a project titled “Small contacts, big decisions – early signal processing by T cells”. This has been awarded jointly with Professor Anna Lippert of the University of Würzburg.

Transformative treatments for children with fatal genetic lung diseases

AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.

Launch of the new BHF Oxford Centre of Research Excellence

Celebrating a £5million British Heart Foundation renewal award to the University of Oxford to advance cardiovascular science.

Under-40s diagnosed with type 2 diabetes have a mortality rate four times higher than the general population

People diagnosed with type 2 diabetes before 40 years of age, have nearly four times the risk of death compared with the general UK population, a new study carried out at the University of Oxford’s Radcliffe Department of Medicine has found.

New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs

Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.

New Cross-Cutting Research Theme Lead for Advanced Therapy Medicinal Products

Researchers develop new tool to better predict acute myeloid leukaemia outcomes in older patients

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Patients receiving steroids are more than twice as likely to develop diabetes, UK study has found

Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, a new study by researchers at the Radcliffe Department of Medicine’s Diabetes Trial Unit has found.

RDM researchers among world-leading cardiologists at ESC Congress 2024

World-leading cardiology experts are to convene at the annual European Society of Cardiology (ESC) Congress in London from tomorrow (Friday 30 August).

Of Mice and Men - Researchers demonstrate evolutionary conservation of blood stem cell subtypes

Researchers from the MRC Weatherall Institute of Molecular Medicine (WIMM) have shown that blood stem cell subtypes found in mice also exist in humans. This provides important information for research into therapies to alleviate the negative effects of aging.

Structure of a key “trigger” of the immune response solved

Grant awarded to develop artificial intelligence tools to understand the bone marrow landscape

Our researchers have received $200,000 to develop artificial intelligence tools to better diagnose what goes wrong in the bone marrow of myeloproliferative neoplasm (MPN) patients.

Vote for AI research shortlisted for the BHF Research Story of the Year award

Voting is open! Some of our British Heart Foundation funded research has been shortlisted for the BHF Research Story of the Year award. Discover more and vote for our work into developing an AI tool to predict people’s risk of having a heart attack years before it happens.

Qiang Zhang appointed Associate Professor of AI in Cardiovascular Imaging

RDM and the Big Data Institute have appointed Dr Qiang Zhang as Associate Professor of AI in Cardiovascular Imaging.

Load More